Introduction {#Sec1}
============

Sesquiterpene quinones/hydroquinones (SQ/SHQ) are common in marine sponges^[@CR1]^, seaweed^[@CR2]^, and marine or terrestrial microorganisms as well^[@CR3],\ [@CR4]^. SQ/SHQ are attractive because of their widely various biological activities, including antitumor^[@CR1]^, antivirus^[@CR5],\ [@CR6]^, antimicrobial^[@CR7],\ [@CR8]^, and NF-κB inhibitory activities^[@CR9]^. Several sponge-derived SQ or SHQ, such as avarol, avarone, illimaquinone, and bolinaquinone, offer promising opportunities for new antitumor agents^[@CR1]^. Sesquiterpene cyclohexenones, structurally closely related to SQ, are relative rare in nature. Most of the cyclohexenone derivatives, obtained from plant-associated and marine-derived fungi, exhibited *in vitro* antitumor^[@CR10]--[@CR12]^ or antimicrobial activities^[@CR13],\ [@CR14]^.

Marine-derived fungi have shown promising potential to produce diverse bioactive metabolites with novel skeletons. During our continuous chemical study of marine-derived fungi, a drimane sesquiterpene cyclohexenone, penicilliumin A (**2**, also named as purpurogemutantidin)^[@CR12]^, was obtained from fungus *Penicillium* sp. F00120 isolated from a deep sea sediment sample in 2012^[@CR11]^. Recently, in order to discover more unique and bioactive compounds from this *Penicillium* strain, the fermentation condition was optimized and a novel sesquiterpene cyclopentenone named penicilliumin B (**1**), represents an unusual drimane sesquiterpene methylcyclopentenedione carbon skeleton, was isolated from the cultures, together with three known cyclohexenone derivatives, penicilliumin A (**2**), macrophorin A (**3**) and purpurogemutantin (**4**). Herein, the isolation, structural determination, plausible bioconversion route, and bioactivity evaluation of these compounds were reported.

Results and Discussion {#Sec2}
======================

The strain of *Penicillium* sp. F00120 was fermented on a solid rice substrate culture. The EtOAc extract of its solid culture was subjected to silica gel and Sephadex LH-20 column chromatography (CC). Compounds **1**--**4** (Fig. [1](#Fig1){ref-type="fig"}) were isolated and purified by semipreparative HPLC finally. The structures of known compounds penicilliumin A (**2**)^[@CR11],\ [@CR12]^, macrophorin A (**3**), and purpurogemutantin (**4**)^[@CR12]^, were determined by NMR data analysis and comparison with the literature data.Figure 1Structures of **1**--**4**.

Penicilliumin B (**1**) was obtained as colorless crystals. Its molecular formula, C~21~H~30~O~3~, was determined by positive HR-ESI-MS (*m/z* 353.2114 \[M + Na\]^+^, calcd for C~21~H~30~O~3~Na, 353.2087; *m/z* 331.2267 \[M + H\]^+^, calcd for C~21~H~31~O~3~, 331.2268), corresponding to seven degrees of unsaturation. The^1^H and^13^C NMR data of **1** (Table [1](#Tab1){ref-type="table"}, Supporting Information, Figures [S10](#MOESM1){ref-type="media"}−[S12](#MOESM1){ref-type="media"}) were closely similar to those of penicilliumin A (**2**)^[@CR11]^, except that the CH~2~ and the CH~2~OH signals in cyclohexenone moiety of **2** were replaced by an exocyclic CH~3~ signal. The same drimane sesquiterpene moiety of **1** with **2** was also confirmed by HSQC, HMBC and ^1^H-^1^H COSY correlations (Fig. [2](#Fig2){ref-type="fig"}, Figures [S13](#MOESM1){ref-type="media"}−[S15](#MOESM1){ref-type="media"}). The key HMBC correlations of H~2~-14 (*δ* ~H~ 1.88, 2.02) with C-16 (*δ* ~C~ 75.5), C-17 (*δ* ~C~ 203.2) and C-20 (*δ* ~C~ 201.6), H-19 (*δ* ~H~ 6.92) with C-16, C-17, C-18 (*δ* ~C~ 160.4), C-20 and C-21 (*δ* ~C~ 11.9), H-21 (*δ* ~H~ 2.07) with C-17, C-18, and C-19 (*δ* ~C~ 142.8), suggested **1** contained a 4-methyl-4-cyclopentene-1,3-dione fragment connecting with C-14 (*δ* ~C~ 29.9), instead of quinone or hexatomic moiety (Fig. [2](#Fig2){ref-type="fig"}). Thus, the whole planar structure of **1** was elucidated.Table 1NMR Spectroscopic Data (500 MHz, CDCl~3~) for Penicilliumin B (**1**).positionδ~H~ (*J* in Hz)δ~C~ (type)positionδ~H~ (*J* in Hz)δ~C~ (type)10.95 (dt, 12.4, 4.2) 1.60 (br d, 12.4)38.5 (CH~2~)120.74 (s)21.5 (CH~3~)21.47 (m) 1.50 (m)19.2 (CH~2~)130.59 (s)14.6 (CH~3~)31.16 (dt, 12.9, 4.5) 1.35 (br d, 12.9)41.8 (CH~2~)141.88\* 2.02 (dd, 14.5, 10.5)29.9 (CH~2~)4/33.6 (C)154.52 (br s), 4.84 (br s)108.3 (CH~2~)51.10 (dd, 12.6, 2.6)55.3 (CH)16/75.5 (C)61.26 (m) 1.72 (m)24.3 (CH~2~)17/203.2 (C)71.91\* 2.32 (ddd, 11.5, 3.7, 2.5)37.9 (CH~2~)18/160.4 (C)8/149.4 (C)196.92 (s)142.8 (CH)91.89\*51.3 (CH)20/201.6 (C)10/40.0 (C)212.07 (s)11.9 (CH~3~)110.84 (s)33.4 (CH~3~)^\*^Overlap. Figure 2Key HMBC^1^, H-^1^H COSY and NOESY correlations of **1**.

The relative configurations were discussed and assigned by NOESY spectrum, especially the observed correlations of H~3~-11/H-5/H-9 and H~3~-12/H~3~-13/H~2~-14 (Fig. [2](#Fig2){ref-type="fig"}, Figure [S16](#MOESM1){ref-type="media"}). A single crystal of **1** was obtained by recrystallization from acetone/methanol system. The structure and absolute configuration of **1** was confirmed by single-crystal X-ray diffraction analysis with Cu K*α* radiation (Fig. [3](#Fig3){ref-type="fig"}). The Flack parameter, 0.02(7), permitted the establishment of the absolute configuration of **1** ^[@CR15]^. Therefore, the overall configuration of **1** was assigned as 5 *S*, 9 *S*, 10 *S*, 16 *S*, and named as penicilliumin B.Figure 3X-ray crystallographic structure of **1**.

A proposed biogenetic pathway for the assembly of **1**−**4** in this fungus was shown in Fig. [4](#Fig4){ref-type="fig"}, and the unusual sesquiterpene methylcyclopentenedione was supposed to be derived from the usual SQ. In brief, the cyclopentenedione moiety of **1** was biosynthesized from epoxy cyclohexenone of **I-3**, by ring contraction, oxidation, and decarboxylation of *β*-keto acids mainly. It is interesting to note that, decarboxylic reaction might also happened in malonylation of **I**-**3** to give sesquiterpene cyclohexenone **4**. Natural cyclopentenediones is rare, and **1** presents the first example with the structure of sesquiterpene cyclopentenedione as natural products.Figure 4Plausible Biosynthetic Pathway of Compounds **1**−**4**.

Sesquiterpene cyclohexenones **2**--**4** were reported with their significant or moderate inhibitory activities against several cancer cells^[@CR11],\ [@CR12]^. However, our bioactive assay showed sesquiterpene methylcyclopentenedione **1** has nearly no inhibitory activities against eight cancer cells (Supporting Information, Table [S1](#MOESM1){ref-type="media"}). Meanwhile, **1** was also inactive in all of the antibacterial (*Escherichia coli*, *Salmonella enterica*, *Staphylococcus aureus*), antituberculosis (*M. tuberculosis* H37Ra), antiviral (H1N1, H3N2, EV71), and anti-inflammatory (COX-1, COX-2, NF-κB luciferase) assays (Supporting Information, Tables [S2](#MOESM1){ref-type="media"}−[S4](#MOESM1){ref-type="media"} and Figure [S1](#MOESM1){ref-type="media"}), much different with SQ or sesquiterpene cyclohexenones derivatives, which are owing broad spectrum of biological activities including those above^[@CR5]--[@CR14]^.

During our studies of screening for renoprotective agent in marine natural products, penicilliumin B (**1**) was showed promising potential to inhibit the kidney fibrogenic action *in vitro*. The results revealed that, **1** with 0.5 μM could significantly inhibit the fibrogenic action of high glucose (HG) in rat glomerular mesangial cells (RMC), as detected by Western blotting analysis of fibronection and collagen I (Fig. [5](#Fig5){ref-type="fig"}), whose production is a main hallmark of renal fibrosis^[@CR16],\ [@CR17]^.Figure 5Penicilliumin B (**1**) inhibits fibrogenic action of high glucose in RMC cells. RMC cells were incubated with D-glucose (25 mM) for 48 h in the absence or presence of different concentrations (0.1, 0.5 μM) of **1**. Cell lysates after various treatments as indicated were immunoblotted with antibodies against fibronectin, collagen I and α-tubulin (**A**). Full-length blots are presented in Supporting Information Figure [S2](#MOESM1){ref-type="media"}. Graphic presentations of fibronectin (**B**) and collagen I (**C**) protein expressions in four groups as indicated. \**p \< *0.05 vs control (n = 3). †*p* \< 0.05 vs HG alone (n = 3).

To further confirm the mechanism of inhibitory effects of **1**, we detected the proliferation and oxidative stress in RMC cells. As shown in Figs [1](#Fig1){ref-type="fig"} and [6](#Fig6){ref-type="fig"}, evidently retarded the proliferation of RMC cells as detected by Western blotting analysis of proliferating cell nuclear antigen (PCNA) and c-myc expression. Considering that the inhibition of fibrosis and proliferation in mesangial cells might be associated with the oxidative stress, the NADPH oxidase activation was explored using Western blotting. The results show that upregulation of two key subunits of NAPDH oxidase, Nox4 and p47phox, were indeed inhibited by **1** (Fig. [7](#Fig7){ref-type="fig"}), suggesting that **1** exerts antifibrotic and antiproliferative actions in RMC cells through disruption of oxidative stress.Figure 6Penicilliumin B (**1**) inhibits proliferative action of high glucose in RMC cells. RMC cells were incubated with D-glucose (25 mM) for 48 h in the absence or presence of different concentrations (0.1, 0.5 μM) of **1**. Cell lysates after various treatments as indicated were immunoblotted with antibodies against PCNA, c-myc and α-tubulin (**A**). Full-length blots are presented in Supporting Information Figure [S3](#MOESM1){ref-type="media"}. Graphic presentations of PCNA (**B**) and c-myc (**C**) protein expressions in four groups as indicated. \**p \< *0.05 vs control (n = 3). †*p \< *0.05 vs HG alone (n = 3). Figure 7Penicilliumin B (**1**) suppresses oxidative stress in RMC cells. RMC cells were incubated with D-glucose (25 mM) for 24 h in the absence or presence of **1** (0.5 μM). NAPDH oxidase subunits of Nox4 and p47phox were analyzed by western blotting (**A**). Full-length blots are presented in Supporting Information Figure [S4](#MOESM1){ref-type="media"}. Graphic presentations of Nox4 (**B**) and p47phox (**C**) protein expressions in three groups as indicated. \**p \< *0.05 vs control (n = 3). ^†^ *p \< *0.05 vs HG alone (n = 3).

Furthermore, normal epithelial human kidney-2 (HK-2) cells were also used for evaluation of nephrotoxicity *in vitro*. Penicilliumin B (**1**) was showed weak toxic effect on HK-2 cells with IC~50~ value 112.6 μM (Supporting Information, Figure [S5](#MOESM1){ref-type="media"}).

In conclusion, a novel drimane sesquiterpene methylcyclopentenedione named penicilliumin B (**1**), was obtained from deep sea-derived fungus *Penicillium* sp. F00120, together with three sesquiterpene cyclohexenones (**2**--**4**). This unusual cyclopentenone skeleton seems to be biosynthesized by losing of one carbon from sesquiterpene quinones, which modifies the redox properties of the hydroquinone-quinone functionality and causes significant change in its bioactivities^[@CR18]^. Penicilliumin B (**1**) was inactive in cytotoxic, antibacterial, antituberculosis, antiviral, and anti-inflammatory assays, however, it was showed to be a promising kidney fibrogenic inhibitor by a mechanism dependent on disruption of oxidative stress in RMC cells, with low toxicity. Although more investigations are needed, our current studies provide proof that penicilliumin B (**1**) can play potential roles in the therapy of diabetic nephropathy, especially on renal fibrotic lesions, presenting a new type of natural product as promising renoprotective agent.

Methods {#Sec3}
=======

General experimental procedures {#Sec4}
-------------------------------

UV and IR spectra were measured on an UV-2401PC spectrometer (Shimadzu, Beijing, China) and IR Affinity-1 spectrometer (Shimadzu, Beijing, China), respectively. Optical rotations were performed on a Perkine Elmer 341 polarimeter, and CD spectra were measured with a chirascan circular dichroism spectrometer (Applied Photophysics, Surrey, UK). HR-ESIMS were determined with a Bruker maXis Q-TOF in positive/negative ion mode. The NMR spectra including (1D and 2D NMR) were recorded on a Bruker AC 500 MHz spectrometer using TMS as standard. All chemical shifts were assigned with δ-values. X-ray diffraction intensity data were collected on Agilent Xcalibur Nova single-crystal diffractometer using Cu Kα radiation. Column chromatography (CC) was performed on silica gel (200--300 mesh, 300--400 mesh), and Sephadex LH-20 (Amersham Biosciences, Sweden), respectively. TLC were carried out on silica gel GF254 (10--40 µm) plates (Qingdao Marine Chemical Factory, China). All solvents used were of analytical grade (Tianjin Fuyu Chemical and Industry Factory). Semipreparative HPLC (Agilent Technologies, 1260 infinity series) was performed using an ODS column (YMC-pack ODS-A, 10 × 250 mm, 5 µm, 1.5 mL/min).

Fungal Material and Fermentation {#Sec5}
--------------------------------

The fungal strain F00120 was obtained from the sediment of the northern South China Sea at a depth of 1300 m, and identified as we reported before^[@CR11]^. Seed medium (potato 200 g, dextrose 20 g, NaCl 5 g, distilled water 1000 mL) in 500-mL Erlenmeyer flasks was inoculated with strain F00120 and incubated at 15 °C for 48 h on a rotating shaker (180 rpm). Production medium of solid rice in 1000 mL flasks (rice 200 g, NaCl 4 g, distilled water 200 mL) was inoculated with 10 mL seed solution. Flasks were incubated at 15 °C under static stations and daylight. After 40 days, cultures from 80 flasks were harvested for chemical study.

Extraction and Isolation {#Sec6}
------------------------

The residue (128 g) was extracted and obtained from the culture medium containing the mycelium, according to the procedures we previously described^[@CR11]^. Then, it was chromatographed on silica gel and eluted with a gradient of petroleum ether (PE)--EtOAc (1:0, 30:1, 20:1, 10:1, 5:1, 1:1, 0:1) to yield 9 fractions (Frs. A1--A9). Fr. A3 (7.2 g) was further separated by silica gel CC and eluted with PE--MeOH (20:1), resulting in 5 fractions (Frs. D1--D5). Fr. D2 (654.5 mg) was chromatographed on a Sephadex LH-20 column using CHCl~3~−MeOH (1:1) to produce 6 fractions (Frs. F1--F6). Fr. F4 (115.4 mg) was finally purified by semipreparative HPLC eluting with 80% MeOH to give compound **1** (25.5 mg, t~R~ 19.5 min). Compound **2** (43.1 mg) was obtained and purified from Fr. A7, much like we previously described^[@CR11]^. Compound **3** (8.5 mg, t~R~ 19.0 min) and **4** (12.6 mg, t~R~ 21.3 min) were also isolated from Fr. A7, finally purified by semipreparative HPLC eluting with 75% MeOH.

New Compound {#Sec7}
------------

X-ray Crystallographic Data of **1**. Orthorhombic, C~21~H~30~O~3~; space group *P* 21 21 21 with *a* = 7.35272(11) Å, *b* = 11.03122(14) Å, *c* = 21.7305(3) Å, *V* = 1762.55(4) Å^3^, *Z* = 4, *D* ~calcd~ = 1.245 Mg/m^3^, *R* ~1~ = 0.0340, *wR* ~2~ = 0.0810, and *R* = 0.0318 for *I* \> 2*σ*(*I*) data. The absolute configuration was determined on the basis of a Flack parameter of −0.2(4), refined using 5213 Friedel pairs. Crystallographic data for the structure of **1** has been deposited in the Cambridge Crystallographic Data Centre as supplementary publication number 1536108. Copies of these data can be obtained free of charge via [www.ccdc.cam.au.ck/conts/retrieving.html](http://www.ccdc.cam.au.ck/conts/retrieving.html) (or from the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB21EZ, UK; fax: (t44) 1223-336-033; or deposit\@ccd.cam.ac.uk).

*Penicilliumin B (* ***1*** *)*: colorless crystals (MeOH); \[α\]^25^ ~D~ + 13.8 (*c* 0.4, MeOH); UV (MeOH) *λ* ~max~: 232 nm (Figure [S6](#MOESM1){ref-type="media"}); IR *ν* ~max~: 3354, 3258, 1703, 1635, 667, 596 cm^−1^ (Figure [S7](#MOESM1){ref-type="media"}); CD (0.5 mM, MeOH) *λ* ~max~ (*Δ*ε) 234 (+16.10), 215 (+8.84) (Figure [S8](#MOESM1){ref-type="media"}); ^1^H and^13^C NMR data, see Table [1](#Tab1){ref-type="table"}; HR-ESI-MS (*m/z* 353.2114 \[M + Na\]^+^, calcd for C~21~H~30~O~3~Na, 353.2087; *m/z* 331.2267 \[M + H\]^+^, calcd for C~21~H~31~O~3~, 331.2268) (Figure [S9](#MOESM1){ref-type="media"}).

Renoprotective assay *in vitro* {#Sec8}
-------------------------------

Rat glomerular mesangial cells (RMC, HBZY-1, Life-Science Academy of Wuhan University, Wuhan, China) were cultured and maintained in DMEM (Invitrogen, Carlsbad, CA), PH7.4, supplemented with 10% fetal bovine serum (FBS, Invitrogen, Carlsbad, CA), 2 mM glutamine, 100 U/ml penicillin, 100 µg/ml streptomycin at 37 °C. To examine the effect of compound **1**, RMC cells were pre-treated with indicated concentration of compound **1** at 37 °C for 1 h, and then exposed to either 5.6 mM (normal glucose, NG) or 25 mM (high glucose, HG) D-glucose for 24 h or 48 h. Whole cell proteins were extracted using a cell lysis buffer kit (Cell signaling, MA, USA) and quantified by the Bradford assay (Bio-Rad, Hercules, CA). The equivalent amount of proteins were resolved with SDS-PAGE and transferred to nitrocellulose membranes. The membranes were blocked and then incubating with a rabbit anti-fibronectin pAb (Sigma, MO, USA), rabbit anti-collagen I (Abcam, MA, USA), rabbit anti-p47phox, rabbit anti-Nox4, rabbit anti-PCNA, rabbit anti-c-myc (all from Santa Cruz, Texas, USA) and mouse anti-α-tubulin (Sigma) at 4 °C overnight. After washing, the membranes were incubated with HRP-conjugated anti-rabbit or anti-mouse IgG secondary antibodies and detected by using ECL detection system.

Toxic effect on normal epithelial human kidney-2 (HK-2) cells {#Sec9}
-------------------------------------------------------------

HK-2, an immortalized proximal tubular cell line derived from normal adult human kidney was obtained from the American Type Culture Collection (ATCC; Manassas, VA, USA), and were grown in Dulbecco's Modified Eagle Media/F12 (D/F12) medium supplemented with 10% FBS in a humidified incubator at 37 °C in the presence of 5% CO~2~. The culture medium was changed every 2 days. HK-2 cell viability was evaluated by the CCK-8 assay. Briefly, HK-2 cells (1 × 10^4^ cells/well) were seeded in 96-well microplates, and then cultured in D/F12 growth medium for 24 h. Subsequently, the medium was replaced with D/F12 growth medium containing different concentrations compound **1** (0.05, 0.5, 4.0, 20.0, 80.0, 160.0, and 320.0 μM). After 48 h, 10 μl of the CCK-8 assay solution was added into each well, followed by incubation of the microplates at 37 °C in 5% CO~2~/95% air for 2 h. Finally, absorption was measured at 450 nm using a microplate reader (PerkinElmer, Inc., Waltham, MA, USA), with a reference wavelength of 650 nm.

Supporting Information {#Sec10}
----------------------

The bioassay (cytotoxic against cancer cells, antibacterial, antituberculosis, antiviral, and antiinflammatory) data of **1**; UV, IR, CD, ^1^H, ^13^C and 2 D NMR spectra of **1** .
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